Full Text
PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis

Abstract

Authors

Z. Philips C. Guarnieri A. Brown

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×